Nephrology

PATIENTS hospitalised due to COVID-19 with end-stage renal disease (ESRD) showed better outcomes than patients with non-dialysis chronic kidney disease (CKD), an observational, retrospective study from New York City, New York, USA, reported.

IMMUNOTHERAPY combined with a targeted kinase inhibitor induces longer overall survival than the current standard treatment in patients with advanced kidney cancer.

SKIN exposure to ultraviolet (UV) light triggers kidney inflammation via neutrophil infiltration and migration in individuals with lupus, a new collaborative study has revealed.

We fondly remember respected nephrologist, researcher, and our EMJ Nephrology editorial board member Prof Donal O’Donoghue.

MAJOR surgery is more likely for individuals with kidney disease compared with people who have normal kidney function.

SOTAGLIFLOZIN is a sodium–glucose cotransporter 2 (SGLT2) inhibitor that may reduce the risk of urgent medical care for heart failure, hospitalisation…

NURSING home residents receiving haemodialysis for chronic kidney disease may be at greater risk of COVID-19. Researchers at the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, identified residents at a nursing home, an already vulnerable population, who were found to have repeated and prolonged exposure to the virus.

MEASURING two proteins in urine of deceased donors may help determine which kidneys are suitable for transplant. The ratio of the proteins can help predict which kidneys were most likely to recover from infection or injury.